Milgamma N (Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride)

Benfotiamine, Cyanocobalamin, and Pyridoxine Hydrochloride, the active ingredients in Milgamma N, are vitamins presented as an oral tablet for oral use. They are combined to support nerve health and address vitamin B deficiencies. GNH USA supplies Milgamma N as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milgamma N is used to support conditions related to nerve function and vitamin B deficiencies. - Vitamin B12 deficiency: restores normal red blood cell formation and neurological function. - Peripheral neuropathy: helps reduce symptoms such as tingling, burning and numbness. - Diabetic neuropathy: may mitigate nerve damage associated with chronic high blood glucose levels.

Milgamma N is generally well tolerated, but some users may experience mild reactions.

Common Side Effects: - Nausea: occasional stomach upset after ingestion. - Abdominal discomfort: mild cramps or bloating. - Headache: transient mild headache. - Skin rash: mild erythema or itching. - Metallic taste: brief aftertaste. - Diarrhoea: loose stools in sensitive individuals.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin eruption. - Worsening neuropathy: unexpected increase in nerve pain. - Blood dyscrasias: abnormal blood counts. - Liver enzyme elevation: signs of hepatic stress. - Thrombocytopenia: low platelet count, increasing bleeding risk.

Before using Milgamma N, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss with a physician as vitamins may pass to infant. - Renal impairment: dosage may need adjustment under medical guidance. - Drug interactions: review concomitant medications for potential conflicts. - Allergies: avoid if known hypersensitivity to any component. - Store at ambient temperature: keep in original container, protect from moisture and light.

Milgamma N may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Methotrexate: increased risk of hematologic toxicity. - Anticonvulsants (e.g., carbamazepine): may accelerate pyridoxine metabolism, reducing efficacy. - Tetracycline antibiotics: can chelate with B vitamins, decreasing absorption.

Moderate Interactions (Monitor Closely): - Metformin: may exacerbate vitamin B12 deficiency; monitor levels. - Proton pump inhibitors: can reduce B12 absorption over long term. - Alcohol: excessive intake may increase neuropathy risk while on B‑vitamin therapy.